Key statistics
As of last trade Guardant Health Inc (5GH:FRA) traded at 29.44, -12.95% below its 52-week high of 33.82, set on Jul 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 29.44 |
---|---|
High | 29.44 |
Low | 29.44 |
Bid | 29.54 |
Offer | 29.82 |
Previous close | 28.91 |
Average volume | 198.89 |
---|---|
Shares outstanding | 123.55m |
Free float | 117.92m |
P/E (TTM) | -- |
Market cap | 3.83bn USD |
EPS (TTM) | -4.24 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 07:07 GMT.
More ▼
Press releases
- Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
- Guardant Health to Participate in Upcoming Investor Conferences
- Guardant Health Named to TIME’s List of the Best Inventions of 2024
- Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Colorectal Cancer Screening at ACG 2024
- Roberto A. Mignone Joins Guardant Health Board of Directors
- Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024
- GOZILA Study Published in Nature Medicine Shows Patients With Advanced Cancer Who Receive Liquid Biopsy-Guided Treatment Using Guardant360 CDx Survive Twice as Long
- Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types
- Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy
More ▼